About this tool
This tool estimates the risk that the bilirubin rises back to the phototherapy threshold after phototherapy is stopped (rebound hyperbilirubinemia), and plans the follow-up bilirubin. It is for babies born at 35 weeks or more after a first course of inpatient phototherapy.
Choose the gestational age band, type the age in hours when phototherapy started, then the TSB and the AAP 2022 phototherapy threshold at the time of stopping (in mg/dL or µmol/L; the jaundice tool gives the threshold). Say where phototherapy was given and whether there is hemolysis.
The result shows the Chang score with each part (15 if under 38 weeks, minus 7 per day of age at start, minus 4 per mg/dL the TSB is below the threshold, plus 50), the risk band (under 20 means under 4%), the AAP 2022 timing of the next bilirubin (6–12 hours and the next day, the next day, or 1–2 days) and when a longer course of phototherapy is an option. Sources: Chang, Pediatrics 2017 and 2019; Kemper, AAP clinical practice guideline, Pediatrics 2022.
Common questions
What is rebound hyperbilirubinemia?
A rise in the total serum bilirubin back to the phototherapy threshold after phototherapy is stopped (AAP 2022: within 72–96 hours). In the US health-system study that built the score, 4.6% of treated babies reached the threshold again within 72 hours.
Which babies are at higher risk of rebound?
Babies under 38 weeks, those who started phototherapy at a younger age (especially before 48 hours), those stopped with a TSB close to the threshold, and babies with hemolysis such as a positive DAT or G6PD deficiency.
When should bilirubin be checked after phototherapy?
AAP 2022: in the birth hospital stay, 6–12 hours after stopping and again the next day if phototherapy started before 48 hours or there is hemolysis; otherwise the next day. After readmission or home phototherapy, 1–2 days after stopping (or a visit to decide). A TcB is only reliable from 24 hours after stopping.
When can phototherapy be stopped?
AAP 2022 says stopping is an option once the TSB is at least 2 mg/dL below the hour-specific threshold at which phototherapy started, with a longer course an option when rebound risk factors are present.